Inflation Reduction Act Reforms Part 2: Changes to Part B and D Drug Benefit Design

In this second part of the three-episode series on the Inflation Reduction Act, host Stephanie Dorvil and guest Joe Metro (Reed Smith, LLP) dig deeper into the IRA’s changes to drug benefit design under Medicare Parts B and D, as well as touch on insulin cost sharing caps. And Joe shares info about a timely opportunity to comment on the inflation rebate provisions before March 11. For more info, see: https://www.cms.gov/inflation-reduction-act-and-medicare.